1) recombinant human hematopoietic synergistic factor
重组人造血增效因子
1.
Objective To evaluate the effects of recombinant human hematopoietic synergistic factor (rhHSF) on rapid mobilization of the peripheral blood stem cells.
目的观察重组人造血增效因子(rhHSF)对外周血造血干/祖细胞的快速动员作用。
2) hHSF
人造血增效因子
1.
Objective To study the relationship between the C-terminal structure of hHSF and its chemotaxis activity.
目的研究人造血增效因子(hHSF)C末端结构与其趋化活性的关系。
3) Recombinant human augmenter of liver regeneration
重组人肝再生增强因子
1.
Recombinant human augmenter of liver regeneration may inhibit gelatinase A gene expression in experimental liver fibrosis;
重组人肝再生增强因子抑制实验性肝纤维化明胶酶A基因表达
2.
Recombinant human augmenter of liver regeneration may promote stromelysin-1 gene expression in experimental liver fibrosis;
重组人肝再生增强因子可促进实验性肝纤维化基质分解素-1的基因表达
3.
Hepatic stellate cell (HSC-T) was cultured in medium containing different concentrations of recombinant human augmenter of liver regeneration (hALR),and cells were collected at different incubation period.
在培养的肝星状细胞系中加入不同浓度的重组人肝再生增强因子 (hALR) ,于不同的时间点收集细胞 ,提取总RNA ,用逆转录定量PCR方法测定Ⅰ、Ⅲ型胶原的基因表达水平。
4) recombinant human thrombopoietin
重组人血小板生成因子
1.
Phase I clinical pharmacokinetics of recombinant human thrombopoietin in healthy volunteers;
重组人血小板生成因子注射液的I期临床药代动力学
5) recombinant human thrombopoietin (rhTPO)
重组人血小板生成因子
1.
Recombinant human thrombopoietin (rhTPO) is a full-length glycosylated molecule produced in a genetically modified mammalian cell line and purified by standard technique by our Chinese boffin, National First new drug.
目的: 血小板生成素(Thrombopoietin,TPO)是近年来新发现的一种造血生长因子,重组人血小板生成因子注射液(Recombinan human thrombopoietin,rhTPO)是我国科技工作者采用重组DNA技术经提纯而制成的全长糖基化人TPO重组蛋白,属于生物制品1类新药。
6) recombinant human activated factorⅦ
重组人活性凝血因子Ⅶ
补充资料：造血细胞生长因子
分子式：
CAS号：
性质：足指一类促使造血干细胞分化的生长因子。如SCF，G-CSF，M-CSF，GM-CSF，EPO，TPO等。
CAS号：
性质：足指一类促使造血干细胞分化的生长因子。如SCF，G-CSF，M-CSF，GM-CSF，EPO，TPO等。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条